JAMES WORRY: Open Payments
NPI 1063791275 · WHITE OAK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,428 in 160 payments from 18 companies in 2025. Trend: 2023 $1,798 · 2024 $1,754 · 2025 $2,428
Food & beverage: $2,343Education: $85
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 22 | $335 |
| Galderma Laboratories, L.P. | 28 | $334 |
| PFIZER INC. | 22 | $320 |
| Incyte Corporation | 13 | $236 |
| LEO Pharma Inc. | 16 | $210 |
| E.R. Squibb & Sons, L.L.C. | 17 | $194 |
| Lilly USA, LLC | 13 | $191 |
| Regeneron Healthcare Solutions, Inc. | 4 | $166 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| GENZYME CORPORATION | 3 | $76 |
Products named: Bimzelx, NEMLUVIO, CIBINQO, DUPIXENT, OPZELURA, Sotyktu, ADBRY, TALTZ.
Industry payments across PA — which companies pay providers there.
